Inventiva 주식 가격. IVA - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

가격

2.16

매수가

2.155

매도가

2.17

거래량

20,530

2.155 일간 변동폭 2.185

1.434 52주 범위 4.30

market_cap

455.049M

전일 종가

2.18

개장가

2.17

최근 거래 시간

2.16

마지막 거래 시간

재정 규모

VWAP

평균 볼륨(3m)

22,005

발행 주식

210,670,845

배당수익률

주가수익률

-4.12

주당순이익(EPS)

-0.52

매출

23.16M

순이익

-110.43M

섹터

Biological Pds,ex Diagnstics

산업

Biological Pds,ex Diagnstics

웹사이트

www.inventivapharma.com

본부

Daix, Fra

설립됨

Inventiva is listed in the Biological Pds,ex Diagnstics sector of the 유로넥스트 (Euronext) with ticker IVA. The last closing price for Inventiva was 2.18 €. Over the last year, Inventiva shares have traded in a share price range of 1.434 € to 4.30 €.

Inventiva currently has 210,670,845 shares in issue. The market capitalisation of Inventiva is 459.26 € million. Inventiva has a price to earnings ratio (PE ratio) of -4.12.

Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux

Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux Daix (France), New York City (New York, Etats-Unis), le 24 janvier 2025 – Inventiva (Euronext Paris...

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux Daix (France), New York City (New York, United States), January 24, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA...

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

Daix (France), New York City (New York, United States), January 24, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company...

Résultats de LEGEND évaluant la combinaison de lanifibranor avec empagliflozine dans la MASH ont été sélectionnés pour présentation orale au EASL SLD Summit 2025

Résultats de LEGEND évaluant la combinaison de lanifibranor avec empagliflozine dans la MASH ont été sélectionnés pour présentation orale au EASL SLD Summit 2025 Daix (France), New York City (New...

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025

Daix (France), New York City (New York, United States), January 22, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company...

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025

Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025 Daix (France), New York City (New York...

Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million

Inventiva secures €21.4 million leading to completion of the first tranche of the financing for c. €116 million, part of the multi-tranche equity financing of up to €348 million announced on...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0.04	1.88679245283	2.12	2.705	2.1	66354	2.41591188	DE
4	-0.03	-1.3698630137	2.19	2.705	2.08	25675	2.32724618	DE
12	-0.285	-11.6564417178	2.445	2.705	2	22005	2.35294148	DE
26	-0.09	-4	2.25	3.2	1.434	37571	2.28298581	DE
52	-1.36	-38.6363636364	3.52	4.3	1.434	45333	2.79709403	DE
156	-8.54	-79.8130841121	10.7	12	1.434	54725	3.72993225	DE
260	-1.9	-46.7980295567	4.06	16.16	1.434	63553	7.08839358	DE

IVA - Frequently Asked Questions (FAQ)

What is the current Inventiva share price?

The current share price of Inventiva is 2.16 €

How many Inventiva shares are in issue?

Inventiva has 210,670,845 shares in issue

What is the market cap of Inventiva?

The market capitalisation of Inventiva is EUR 459.26M

What is the 1 year trading range for Inventiva share price?

Inventiva has traded in the range of 1.434 € to 4.30 € during the past year

What is the PE ratio of Inventiva?

The price to earnings ratio of Inventiva is -4.12

What is the cash to sales ratio of Inventiva?

The cash to sales ratio of Inventiva is 19.65

What is the reporting currency for Inventiva?

Inventiva reports financial results in EUR

What is the latest annual turnover for Inventiva?

The latest annual turnover of Inventiva is EUR 23.16M

What is the latest annual profit for Inventiva?

The latest annual profit of Inventiva is EUR -110.43M

What is the registered address of Inventiva?

The registered address for Inventiva is 50 RUE DE DIJON, DAIX, 21121

What is the Inventiva website address?

The website address for Inventiva is www.inventivapharma.com

Which industry sector does Inventiva operate in?

Inventiva operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
NICBSNicox SA	0.0264 € (45.86%)	198
ALENTEntreparticuliersCom	0.578 € (28.44%)	16.94k
FPGUnion Tech Info	0.344 € (28.36%)	126.15k
MLOCTOctopus Biosafety	0.178 € (27.14%)	3.89k
ALDVAlliance Developpement Capital Siic	0.0695 € (25.23%)	10k
BIODSBiosynex DS	0.0278 € (-30.50%)	72.52k
MLCLPColipays	1.06 € (-25.87%)	74
ALVERVergnet	0.001 € (-23.08%)	79.31M
MLSTRStreit Mecanique	7.70 € (-19.79%)	20
MLSRPSpeed Rabbit Pizza	13.20 € (-18.52%)	91
ATOAtos SE	0.0021 € (0.00%)	599.35M
ALVERVergnet	0.001 € (-23.08%)	79.31M
BCPBanco Comercial Portugues SA	0.5086 € (1.64%)	48.29M
ALHPIHopium SA	0.0031 € (-6.06%)	27.89M
ALNRGEnergisme SA	0.0044 € (0.00%)	24.22M